Hidradenoma papilliferum is a benign cystic tumor originated in apocrine sweat glands of the anogenital region. It is common in vulvar topography and rare in the perianal region.
Introduction
Hidradenoma papilliferum is a benign cystic tumor, predominant in women aged 30-50 years. 1 Originating in the apocrine sweat glands of the anogenital region, this tumor affects the vulva preferentially, being uncommon in other topographies. Cooper and Mac Donald, in 1944, described the first case of perianal hidradenoma papilliferum 2 ; since then, less than 20 cases have been published to date. Due to the small number of cases, this article reports a well-documented case of hidradenoma papilliferum with a perianal location.
Case report
The patient is a 31-year-old, brown-colored woman. She has been exhibiting a slow-growing perianal nodule for one year without pain or other symptoms. Deny comorbidities or addictions; her mother died of breast adenocarcinoma. At the examination, we observed a cystic nodulation of 10 mm in diameter located 1 cm from the anal border ( Fig. 1) , without other changes in the proctological and gynecological examination. The patient was submitted to total excision of the lesion under local anesthesia, and her histological diagnosis was hidradenoma papilliferum ( Fig. 2A and B) .
Discussion
Hidradenoma papilliferum is a rare benign tumor, originating in the apocrine sweat glands of the anogenital region. The literature describes this lesion as a tumor that affects almost exclusively Caucasian postpubertal women, although the case described is a brown-colored woman. The mean
Fig. 1 -Perianal cystic nodulation.
age of patients with perianal lesions is higher (approximately 45 years) versus patients with vulvar lesions (approximately 39 years). The occurrence of this tumor in men is rare, 3 and some authors consider it as an accessory mammary gland tumor. 2 The most common site of involvement is the vulva, especially the large lips. Less frequently, the tumor may also present in the small lips, interlabial sulcus, clitoris, posterior fourchette, pubis, perineum, anal region, and in extragenital sites. 1, 4 The vulvar occurrence is four times more frequent than perianal occurrence.
Clinically, the tumor presents as a single, painless, small (<2 cm), unilateral nodule, with an overlying intact skin, of fibroelastic consistency, with precise limits, and with mobility; may also be of a polypous, vegetative or cystic nature. Rarely there is symptomatology in the perianal region; but in some cases, symptoms such as pain, a burning sensation, discharge, bleeding, and pruritus may be present as a result of fecal transit.
Histologically, the tumor is located in the dermis, unrelated to the epidermis; and is limited by fibrous connective tissue. The tumor consists of a conglomerate of glandular acini, tubules and small cysts covered with papillae with a double cell layer, the first with clear cuboidal or columnar cells with a basal nucleus (PAS positive) and the second with contiguous myoepithelial cells. 5 The absence of connective tissue in the papillary structure distinguishes hidradenoma papilliferum from syringocystoadenoma papilliferum. 6 The literature is controversial about the evolution of this tumor to cancer. Many authors consider the possibility of malignancy, while others believe that this does not occur. 2, 5 Adenomatous hyperplasia with cellular pleomorphism and an irregular papillary pattern of the acinus without lumen formation motivate a speculation about its malignant potential; sometimes this lesion is even diagnosed as adenocarcinoma. But a careful critical reassessment of suspected cases of malignancy, often misinterpreted as adenocarcinomas, has shown that, in most cases, they were, histologically, cases of hidradenoma papilliferum. 1 The spectrum of differential diagnoses is broad, comprising more commonly benign lesions such as hemorrhoidal disease, anorectal abscess, viral verrucous lesion, sebaceous cyst, lipoma, and neurofibroma; and malignant lesions, such as metastatic papillary carcinoma, syringocystoadenocarcinoma papilliferum, and squamous cell carcinoma. Excisional biopsy confirms the diagnosis.
Local excision with a margin will be sufficient for its diagnosis, treatment, and cure. 6 In conclusion, considering the histological diversity of the anal region, dermatological diseases are a differential diagnosis of proctological conditions. A biopsy is mandatory for all anal lesions with unusual presentation.
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